Rachel E Brown1,2, Sarah P Short1,3, Christopher S Williams1,2,3,4,5. 1. Program in Cancer Biology, Vanderbilt University, Nashville, TN, USA. 2. Vanderbilt University School of Medicine, Vanderbilt University, Nashville, TN, USA. 3. Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, B2215 Garland Ave., 1065D MRB-IV, Nashville, TN 37232-0252, USA. 4. Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA. 5. Veterans Affairs Tennessee Valley HealthCare System, Nashville, TN, USA.
Abstract
PURPOSE OF REVIEW: Metabolic reprogramming is essential for the rapid proliferation of cancer cells and is thus recognized as a hallmark of cancer. In this review, we will discuss the etiologies and effects of metabolic reprogramming in colorectal cancer. RECENT FINDINGS: Changes in cellular metabolism may precede the acquisition of driver mutations ultimately leading to colonocyte transformation. Oncogenic mutations and loss of tumor suppressor genes further reprogram CRC cells to upregulate glycolysis, glutaminolysis, one-carbon metabolism, and fatty acid synthesis. These metabolic changes are not uniform throughout tumors, as subpopulations of tumor cells may rely on different pathways to adapt to nutrient availability in the local tumor microenvironment. Finally, metabolic cross-communication between stromal cells, immune cells, and the gut microbiota enable CRC growth, invasion, and metastasis. SUMMARY: Altered cellular metabolism occurs in CRC at multiple levels, including in the cells that make up the bulk of CRC tumors, cancer stem cells, the tumor microenvironment, and host-microbiome interactions. This knowledge may inform the development of improved screening and therapeutics for CRC.
PURPOSE OF REVIEW: Metabolic reprogramming is essential for the rapid proliferation of cancer cells and is thus recognized as a hallmark of cancer. In this review, we will discuss the etiologies and effects of metabolic reprogramming in colorectal cancer. RECENT FINDINGS: Changes in cellular metabolism may precede the acquisition of driver mutations ultimately leading to colonocyte transformation. Oncogenic mutations and loss of tumor suppressor genes further reprogram CRC cells to upregulate glycolysis, glutaminolysis, one-carbon metabolism, and fatty acid synthesis. These metabolic changes are not uniform throughout tumors, as subpopulations of tumor cells may rely on different pathways to adapt to nutrient availability in the local tumor microenvironment. Finally, metabolic cross-communication between stromal cells, immune cells, and the gut microbiota enable CRC growth, invasion, and metastasis. SUMMARY: Altered cellular metabolism occurs in CRC at multiple levels, including in the cells that make up the bulk of CRC tumors, cancer stem cells, the tumor microenvironment, and host-microbiome interactions. This knowledge may inform the development of improved screening and therapeutics for CRC.
Authors: Yardena Samuels; Zhenghe Wang; Alberto Bardelli; Natalie Silliman; Janine Ptak; Steve Szabo; Hai Yan; Adi Gazdar; Steven M Powell; Gregory J Riggins; James K V Willson; Sanford Markowitz; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu Journal: Science Date: 2004-03-11 Impact factor: 47.728
Authors: J K Chung; Y J Lee; C Kim; S R Choi; M Kim; K Lee; J M Jeong; D S Lee; J J Jang; M C Lee Journal: J Nucl Med Date: 1999-02 Impact factor: 10.057
Authors: Jeffrey C Rathmell; Casey J Fox; David R Plas; Peter S Hammerman; Ryan M Cinalli; Craig B Thompson Journal: Mol Cell Biol Date: 2003-10 Impact factor: 4.272
Authors: Johanne Bentley; Dalina Itchayanan; Kay Barnes; Elizabeth McIntosh; Xiuwen Tang; C Peter Downes; Geoffrey D Holman; Anthony D Whetton; P Jane Owen-Lynch; Stephen A Baldwin Journal: J Biol Chem Date: 2003-07-16 Impact factor: 5.157
Authors: Jiaqi Li; Jie Qing Eu; Li Ren Kong; Lingzhi Wang; Yaw Chyn Lim; Boon Cher Goh; Andrea L A Wong Journal: Molecules Date: 2020-10-20 Impact factor: 4.411